Stat5 as a diagnostic marker for leukemia.
The Jak-Stat-Socs pathway is an important component of cytokine receptor signaling. Not surprisingly, perturbation of this pathway is implicated in diseases of hematopoietic and immune origin, including leukemia, lymphoma and immune deficiencies. This review examines the role of a key component of this pathway, Stat5. This has been shown to be activated in a variety of leukemias and myeloproliferative disorders, including downstream of a range of key oncogenes where it has been shown to play an important role in mediating their effects. Therefore, Stat5 represents a useful pan-leukemia/myeloproliferative disorder diagnostic marker and key therapeutic end point, as well as representing an attractive therapeutic target for these disorders.
Lewis
Rowena S
RS
Cancer & Haematology Division, The Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, 3050, Australia. lewis@wehi.edu.au
Ward
Alister C
AC
D014408:Biomarkers, Tumor / Q000378:metabolism*; D006801:Humans; D007938:Leukemia / Q000175:diagnosis*; D050799:STAT5 Transcription Factor / Q000378:metabolism*
D014408:Biomarkers, Tumor; D050799:STAT5 Transcription Factor